Westell Stockholders Approve Reverse Stock Split
May 31, 2017 13:26 pm UTC| Business
AURORA, Ill., May 31, 2017 -- Westell Technologies, Inc.(NASDAQ:WSTL), a leading provider of high-performance wireless infrastructure solutions, announced that at a special meeting held on May30, 2017, stockholders...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%
May 31, 2017 13:26 pm UTC| Business
Press Release Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24% First approved US NDA for Nicox First topical ocular formulation of the antihistamine cetirizine U.S. ...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight